Home/Filings/4/0001415889-21-004371
4//SEC Filing

Coelho Mary Theresa 4

Accession 0001415889-21-004371

CIK 0001604191other

Filed

Sep 12, 8:00 PM ET

Accepted

Sep 13, 8:08 PM ET

Size

5.7 KB

Accession

0001415889-21-004371

Insider Transaction Report

Form 4
Period: 2021-09-09
Transactions
  • Award

    Stock option (right to buy)

    2021-09-09+10,31010,310 total
    Exercise: $0.64Exp: 2031-09-09Common stock, par value $0.0001 per share (10,310 underlying)
Footnotes (2)
  • [F1]The number of derivative securities reported has not been adjusted to reflect the 10-for-1 reverse stock split of AzurRx BioPharma, Inc. common stock that occurred on September 13, 2021.
  • [F2]The stock option vests on December 31, 2021.

Issuer

AzurRx BioPharma, Inc.

CIK 0001604191

Entity typeother

Related Parties

1
  • filerCIK 0001720772

Filing Metadata

Form type
4
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 8:08 PM ET
Size
5.7 KB